Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04603040 |
| Consolidated Lead Sponsor | Shanghai Junshi Bioscience Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 17 participants (ACTUAL) |
| Registered Start Date | 2020-09-28 |
| WhyStopped Classification | Unspecified |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou, China | Open Hospital Dossier -> |
| Affiliated Hospital of Hebei University | Baoding, China | Open Hospital Dossier -> |
| Sichuan Cancer Hospital | Chengdu, China | Open Hospital Dossier -> |
| Guangdong Provincial People's Hospital | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.